Publication
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
102 J'aime5 Je n'aime pas10 Republications1 Commentaires
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
Aucun commentaire pour le moment. Soyez le premier !
Commentaires
Aucun commentaire pour le moment. Soyez le premier !